Literature DB >> 20025176

[Relapse after surgical treatment of mycobacterium ulcerans infection (buruli ulcer): study of risk factors in 84 patients in the Democratic Republic of the Congo].

K Kibadi1, J B Mputu-Yamba, B Mokassa, M Panda, J J Muyembe-Tamfum.   

Abstract

OBJECTIVE: To identify risk factors for relapse after exclusively surgical treatment of Mycobacterium ulcerans infection (Buruli ulcer).
METHODS: Study was carried out in 102 patients treated exclusively by surgery for Buruli ulcer at various care facilities in the Congo from January 1, 2000 to January 1, 2005.
RESULTS: Outcomes included relapse in 22 patients (21.5%), cure in 62 (60.7%), and unknown in 18 (17.6%). Statistical analysis identified the following variables as independent risk factors for relapse after exclusively surgical treatment: incomplete surgical excision (OR = 91.83; P = 0.0000; IC to 95%), age under 16 years (OR = 14.80; P = 0.0000; IC to 95%) and pre-ulcerative Buruli lesions (edema and plaque) (OR = 3.18; P = 0.0215; IC to 95%).
CONCLUSION: Quality of excision, patient age, and clinical form of lesion are the main predictors of relapse after isolated surgical treatment of Buruli ulcer.

Entities:  

Mesh:

Year:  2009        PMID: 20025176

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  3 in total

1.  Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?

Authors:  Raquel Cowan; Eugene Athan; N Deborah Friedman; Andrew J Hughes; Anthony McDonald; Peter Callan; Janet Fyfe; Daniel P O'Brien
Journal:  PLoS Negl Trop Dis       Date:  2015-02-06

Review 2.  Buruli Ulcer: a Review of the Current Knowledge.

Authors:  Rie R Yotsu; Koichi Suzuki; Rachel E Simmonds; Roger Bedimo; Anthony Ablordey; Dorothy Yeboah-Manu; Richard Phillips; Kingsley Asiedu
Journal:  Curr Trop Med Rep       Date:  2018-09-28

3.  Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice.

Authors:  Aurélie Chauffour; Jérôme Robert; Nicolas Veziris; Alexandra Aubry; Vincent Jarlier
Journal:  PLoS Negl Trop Dis       Date:  2016-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.